Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency.
Saved in:
| Title: | Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency. |
|---|---|
| Authors: | Aboumatar S; Austin Epilepsy Care Center, Austin, TX, USA. Electronic address: sami@austinepilepsy.com., Biton V; Arkansas Epilepsy Program, Little Rock, AR, USA., Wechsler R; St. Luke's Boise Medical Center, Idaho Comprehensive Epilepsy Center, Boise, ID, USA., Ferrari L; SK Life Science, Inc., Paramus, NJ, USA., Rosenfeld WE; Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, MO, USA. |
| Source: | Epilepsy research [Epilepsy Res] 2022 Oct; Vol. 186, pp. 107014. Date of Electronic Publication: 2022 Aug 27. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8703089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-6844 (Electronic) Linking ISSN: 09201211 NLM ISO Abbreviation: Epilepsy Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1872-6844 |
|---|---|
| DOI: | 10.1016/j.eplepsyres.2022.107014 |
